TW577739B - Pharmaceutical composition comprising celecoxib for maintaining circulation through fetal ductus arteriosus during treatment or prevention of preterm labor - Google Patents

Pharmaceutical composition comprising celecoxib for maintaining circulation through fetal ductus arteriosus during treatment or prevention of preterm labor Download PDF

Info

Publication number
TW577739B
TW577739B TW087118094A TW87118094A TW577739B TW 577739 B TW577739 B TW 577739B TW 087118094 A TW087118094 A TW 087118094A TW 87118094 A TW87118094 A TW 87118094A TW 577739 B TW577739 B TW 577739B
Authority
TW
Taiwan
Prior art keywords
group
groups
alkyl
term
acid
Prior art date
Application number
TW087118094A
Other languages
English (en)
Chinese (zh)
Inventor
Philip Needleman
Jaime Masferrer
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Application granted granted Critical
Publication of TW577739B publication Critical patent/TW577739B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/06—Anti-spasmodics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
TW087118094A 1997-10-31 1998-10-30 Pharmaceutical composition comprising celecoxib for maintaining circulation through fetal ductus arteriosus during treatment or prevention of preterm labor TW577739B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6388997P 1997-10-31 1997-10-31

Publications (1)

Publication Number Publication Date
TW577739B true TW577739B (en) 2004-03-01

Family

ID=22052179

Family Applications (2)

Application Number Title Priority Date Filing Date
TW092134686A TW200404535A (en) 1997-10-31 1998-10-30 Pharmaceutical composition for maintaining circulation through fetal ductus arteriosus during treatment or prevention of preterm labor
TW087118094A TW577739B (en) 1997-10-31 1998-10-30 Pharmaceutical composition comprising celecoxib for maintaining circulation through fetal ductus arteriosus during treatment or prevention of preterm labor

Family Applications Before (1)

Application Number Title Priority Date Filing Date
TW092134686A TW200404535A (en) 1997-10-31 1998-10-30 Pharmaceutical composition for maintaining circulation through fetal ductus arteriosus during treatment or prevention of preterm labor

Country Status (9)

Country Link
EP (1) EP1027048A2 (pt)
JP (1) JP2001521889A (pt)
AR (1) AR014000A1 (pt)
AU (1) AU758566B2 (pt)
BR (1) BR9813164A (pt)
CA (1) CA2308639A1 (pt)
TW (2) TW200404535A (pt)
WO (1) WO1999022720A2 (pt)
ZA (1) ZA989876B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001274858A1 (en) * 2000-06-08 2001-12-17 Board Of Regents, The University Of Texas System Heterocycle derivatives and methods of use for treating anthrax infection
PT1534305E (pt) 2003-05-07 2007-02-28 Osteologix As Tratamento de afecções cartilagineas / osseas com sais de estroncio hidrosoluveis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2161789A1 (en) * 1993-05-13 1994-11-24 Jacques Yves Gauthier 2-substituted-3,4-diarylthiophene derivatives as inhibitors of cyclooxygenase
US5474995A (en) * 1993-06-24 1995-12-12 Merck Frosst Canada, Inc. Phenyl heterocycles as cox-2 inhibitors
US5466823A (en) * 1993-11-30 1995-11-14 G.D. Searle & Co. Substituted pyrazolyl benzenesulfonamides
WO1997031631A1 (en) * 1996-02-27 1997-09-04 Rpms Technology Limited Cox-2 selective inhibitors for managing labour and uterine contractions
US5677318A (en) * 1996-07-11 1997-10-14 Merck Frosst Canada, Inc. Diphenyl-1,2-3-thiadiazoles as anti-inflammatory agents

Also Published As

Publication number Publication date
AR014000A1 (es) 2001-01-31
CA2308639A1 (en) 1999-05-14
WO1999022720A3 (en) 1999-08-26
BR9813164A (pt) 2000-08-22
WO1999022720A2 (en) 1999-05-14
ZA989876B (en) 1999-10-29
JP2001521889A (ja) 2001-11-13
AU1192699A (en) 1999-05-24
EP1027048A2 (en) 2000-08-16
TW200404535A (en) 2004-04-01
AU758566B2 (en) 2003-03-27

Similar Documents

Publication Publication Date Title
TWI235060B (en) Pharmaceutical compositions comprising substituted pyrazolyl benzenesulfonamide derivatives for use in treating or preventing an epithelial cell-derived neoplasia
EP0843549B1 (en) Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene a 4 hydrolase inhibitor
Brogden Pyrazolone derivatives
US6342510B1 (en) Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitors and a leukotriene B4 receptor antagonist
AU7466298A (en) Method of using cyclooxygenase-2 inhibitors in the prevention of cardiovascular disorders
US20040082543A1 (en) Compositions of cyclooxygenase-2 selective inhibitors and NMDA receptor antagonists for the treatment or prevention of neuropathic pain
JPH0324447B2 (pt)
JP2001506574A (ja) シクロオキシゲナーゼ―２阻害剤およびロイコトリエンａ４ヒドロラーゼ阻害剤を含有する免疫抑制効果をもつ配合物
PT1429807E (pt) Combinação de um nsaid e de um inibidor de pde-4
US20030114509A1 (en) Prophylactic or therapeutic drug for renal diseases
JP2007509968A (ja) 新形成を治療または予防するためのｈｓｐ９０阻害剤およびホスホジエステラーゼ阻害剤を含む組み合わせ
JP2004521856A (ja) Ｃｏｘ−２選択的阻害剤およびトロンボキサン阻害剤を用いる併用療法ならびにそのための組成物
CZ20001376A3 (cs) Prostředek obsahující steroid a inhibitor PDE4
JPH10511080A (ja) 哺乳類細胞の増殖を治療するためのハロゲン化芳香族の使用
ES2358931T3 (es) Uso de un inhibidor de quinasa p38 para el tratamiento de trastornos psiquiatricos.
US20020035156A1 (en) Combination therapy in the prevention of cardiovascular disorders
TW577739B (en) Pharmaceutical composition comprising celecoxib for maintaining circulation through fetal ductus arteriosus during treatment or prevention of preterm labor
US20070072861A1 (en) Method of using cyclooxygenase-2 inhibitors in the prevention of cardiovascular disorders
TW383222B (en) Pharmaceutical composition of bicycloheptane derivatives
RU2768875C2 (ru) Композиции для лечения и профилактики вазомоторных симптомов
JP2001504484A (ja) ネファゾドンの外傷後ストレス障害における使用
US20050143360A1 (en) Method of using a cyclooxygenase-2 inhibitor and sex steroids as a combination therapy for the treatment and prevention of dismenorrhea
BR112012000410B1 (pt) uso de benzidamina ou dos sais de adição de ácido, e, composição farmacêutica
JP2006508032A (ja) 糖質コルチコイド調節不全を有する対象におけるｔ細胞媒介炎症性／自己免疫性疾患および障害を治療するための方法および組成物
KR20190013847A (ko) 불안 장애를 치료하기 위한 (2S)-1-[4-(3,4-디클로로페닐)피페리딘-1-일]-3-[2-(5-메틸-1,3,4-옥사디아졸-2-일)벤조[b]푸란-4-일옥시]프로판-2-올 또는 그의 대사산물

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees